ViviCells Historical Financial Ratios

VCII Stock  USD 0.0001  0.00  0.00%   
ViviCells International is promptly reporting on over 101 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.17, Ptb Ratio of 5.62, Days Sales Outstanding of 242 or Book Value Per Share of 0.0068 will help investors to properly organize and evaluate ViviCells International financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ViviCells International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.

About ViviCells Financial Ratios Analysis

ViviCells InternationalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate ViviCells International investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on ViviCells financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across ViviCells International history.

ViviCells International Financial Ratios Chart

As of now, ViviCells International's Debt To Assets are decreasing as compared to previous years. The ViviCells International's current Price Book Value Ratio is estimated to increase to 5.62, while Book Value Per Share is projected to decrease to 0.01.
Add Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Invested CapitalAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowEarnings Yield
Intangibles To Total AssetsNet Debt To E B I T D A
Current RatioTangible Book Value Per Share
Receivables TurnoverGraham Number
Shareholders Equity Per ShareDebt To Equity
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldFree Cash Flow Yield
Operating Cash Flow Per ShareFree Cash Flow Per Share
Payout RatioCapex Per Share
Price Earnings RatioPrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityShort Term Coverage Ratios
Operating CycleDividend Payout Ratio
Cash Conversion CycleCash Flow Coverage Ratios
Cash Flow To Debt Ratio

Price To Sales Ratio

Price to Sales Ratio is figured by comparing ViviCells International stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on ViviCells International sales, a figure that is much harder to manipulate than other ViviCells International multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Earnings Yield

The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.
Most ratios from ViviCells International's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into ViviCells International current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ViviCells International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.As of now, ViviCells International's Debt To Assets are decreasing as compared to previous years. The ViviCells International's current Price Book Value Ratio is estimated to increase to 5.62, while Book Value Per Share is projected to decrease to 0.01.
 2023 2024 (projected)
PTB Ratio5.355.62
Price To Sales Ratio0.190.17

ViviCells International fundamentals Correlations

-0.421.00.1-0.83-0.421.0-0.421.0-0.11.01.01.00.1-0.79-0.79-0.82-0.831.01.0-0.09-0.820.50.26-0.82-0.35
-0.42-0.42-0.20.411.0-0.411.0-0.420.2-0.42-0.42-0.42-0.20.40.40.410.41-0.42-0.420.080.41-0.98-0.170.410.8
1.0-0.420.1-0.81-0.421.0-0.411.0-0.11.01.01.00.1-0.77-0.76-0.8-0.811.01.0-0.09-0.80.50.26-0.8-0.35
0.1-0.20.1-0.1-0.20.1-0.20.1-1.00.10.10.11.0-0.1-0.1-0.1-0.10.10.1-0.03-0.10.210.51-0.10.1
-0.830.41-0.81-0.10.41-0.80.41-0.810.1-0.81-0.81-0.81-0.11.01.01.01.0-0.81-0.810.111.0-0.52-0.241.00.36
-0.421.0-0.42-0.20.41-0.411.0-0.420.2-0.42-0.42-0.42-0.20.40.40.410.41-0.42-0.420.080.41-0.98-0.170.410.8
1.0-0.411.00.1-0.8-0.41-0.411.0-0.11.01.01.00.1-0.76-0.75-0.79-0.81.01.0-0.09-0.790.490.26-0.79-0.35
-0.421.0-0.41-0.20.411.0-0.41-0.420.2-0.41-0.41-0.41-0.20.40.40.410.41-0.41-0.410.060.41-0.98-0.190.410.79
1.0-0.421.00.1-0.81-0.421.0-0.42-0.11.01.01.00.1-0.78-0.77-0.81-0.811.01.0-0.09-0.810.50.26-0.81-0.35
-0.10.2-0.1-1.00.10.2-0.10.2-0.1-0.1-0.1-0.1-1.00.10.10.10.1-0.1-0.10.030.1-0.21-0.510.1-0.1
1.0-0.421.00.1-0.81-0.421.0-0.411.0-0.11.01.00.1-0.77-0.77-0.8-0.811.01.0-0.09-0.80.50.26-0.8-0.35
1.0-0.421.00.1-0.81-0.421.0-0.411.0-0.11.01.00.1-0.77-0.76-0.8-0.811.01.0-0.09-0.80.50.26-0.8-0.35
1.0-0.421.00.1-0.81-0.421.0-0.411.0-0.11.01.00.1-0.77-0.77-0.81-0.811.01.0-0.09-0.810.50.26-0.8-0.35
0.1-0.20.11.0-0.1-0.20.1-0.20.1-1.00.10.10.1-0.1-0.1-0.1-0.10.10.1-0.03-0.10.210.51-0.10.1
-0.790.4-0.77-0.11.00.4-0.760.4-0.780.1-0.77-0.77-0.77-0.11.01.01.0-0.77-0.770.111.0-0.51-0.241.00.35
-0.790.4-0.76-0.11.00.4-0.750.4-0.770.1-0.77-0.76-0.77-0.11.01.01.0-0.77-0.770.111.0-0.51-0.241.00.35
-0.820.41-0.8-0.11.00.41-0.790.41-0.810.1-0.8-0.8-0.81-0.11.01.01.0-0.8-0.80.111.0-0.52-0.241.00.36
-0.830.41-0.81-0.11.00.41-0.80.41-0.810.1-0.81-0.81-0.81-0.11.01.01.0-0.81-0.810.111.0-0.52-0.241.00.36
1.0-0.421.00.1-0.81-0.421.0-0.411.0-0.11.01.01.00.1-0.77-0.77-0.8-0.811.0-0.09-0.80.50.26-0.8-0.35
1.0-0.421.00.1-0.81-0.421.0-0.411.0-0.11.01.01.00.1-0.77-0.77-0.8-0.811.0-0.09-0.80.50.26-0.8-0.35
-0.090.08-0.09-0.030.110.08-0.090.06-0.090.03-0.09-0.09-0.09-0.030.110.110.110.11-0.09-0.090.11-0.20.80.110.6
-0.820.41-0.8-0.11.00.41-0.790.41-0.810.1-0.8-0.8-0.81-0.11.01.01.01.0-0.8-0.80.11-0.52-0.241.00.36
0.5-0.980.50.21-0.52-0.980.49-0.980.5-0.210.50.50.50.21-0.51-0.51-0.52-0.520.50.5-0.2-0.520.1-0.52-0.85
0.26-0.170.260.51-0.24-0.170.26-0.190.26-0.510.260.260.260.51-0.24-0.24-0.24-0.240.260.260.8-0.240.1-0.240.44
-0.820.41-0.8-0.11.00.41-0.790.41-0.810.1-0.8-0.8-0.8-0.11.01.01.01.0-0.8-0.80.111.0-0.52-0.240.36
-0.350.8-0.350.10.360.8-0.350.79-0.35-0.1-0.35-0.35-0.350.10.350.350.360.36-0.35-0.350.60.36-0.850.440.36
Click cells to compare fundamentals

ViviCells International Account Relationship Matchups

Currently Active Assets on Macroaxis

When determining whether ViviCells International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ViviCells International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivicells International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivicells International Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ViviCells International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Independent Power and Renewable Electricity Producers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.27)
The market value of ViviCells International is measured differently than its book value, which is the value of ViviCells that is recorded on the company's balance sheet. Investors also form their own opinion of ViviCells International's value that differs from its market value or its book value, called intrinsic value, which is ViviCells International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ViviCells International's market value can be influenced by many factors that don't directly affect ViviCells International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.